Lifeline Systems News

CARLSBAD, Calif. and GAITHERSBURG, Md., May 30, 2012 /PRNewswire via COMTEX/ -- Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of ... (more)

Complete Genomics, Inc. : After Complete Genomics and a number of other small-cap genomic stocks surged over the past two days, Mizuho sees no news to justify the rallies.

The firm set a "neutral" rating on the stock. A number of other analysts have also recently weighed in on LIFE.

Life Technologies has had an interesting 2012 so far. It started the year at around $39 a share, shot up to $50 in February and have sold off with the overall market in the last two months and its shares are back down to $42 a share.

Life Technologies in Carlsbad says it is donating $3 million to the Smithsonian Institution to become lead sponsor of a major exhibit that explains and celebrates the 10th anniversary of the completion of the Human Genome Project, which is widely considered one of the greatest scientific achievements in history.

UC San Diego hosted a meet and greet to welcome Chancellor-Designate Pradeep Khosla on Thursday morning.

Shares of Life Technologies Corporation opened at 43.48 on Tuesday. Life Technologies Corporation has a 52 week low of $35.30 and a 52 week high of $55.30. The company has a market cap of $7.764 billion and a P/E ratio of 19.19. A number of other analysts have also recently weighed in on LIFE.

As the United Kingdom's representative in Southern California, I'm lucky to interact with all sorts of visitors from Britain - businesspeople, cultural leaders, academics, tourists.